Q1 2025 · 13F-HR
Nextech Invest, Ltd.holdings as filed
Filed 2025-05-15 · accession 0001415889-25-013146
$430.3M
Reported value
15
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $268.8M | 62.5% | 7,601,087 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $37.7M | 8.77% | 4,055,861 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $29.5M | 6.85% | 5,285,714 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $13.3M | 3.08% | 1,113,946 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $11.8M | 2.74% | 936,729 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $10.8M | 2.50% | 2,642,502 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $10.1M | 2.34% | 3,846,409 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $9.9M | 2.30% | 1,408,394 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $9.1M | 2.11% | 1,476,998 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $8.6M | 2.01% | 1,141,145 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $7.6M | 1.76% | 5,533,980 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $4.5M | 1.06% | 7,419,355 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $4.2M | 0.97% | 12,067,246 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $2.7M | 0.62% | 952,400 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $1.9M | 0.43% | 1,228,069 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.